You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR RITUXAN HYCELA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for RITUXAN HYCELA

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02972840 ↗ A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL Recruiting Acerta Pharma BV Phase 3 2017-04-05 This study is evaluating the efficacy of acalabrutinib in combination with bendamustine and rituximab (BR) compared with placebo plus BR in subjects with previously untreated mantle cell lymphoma.
NCT03467867 ↗ A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL Recruiting Hackensack Meridian Health Phase 2 2018-04-26 This is an open-label, multicenter, Phase II study to investigate the efficacy and safety of venetoclax in combination with Rituximab/hyaluronidase human in participants with relapsed or refractory chronic lymphocytic leukemia (CLL).
NCT03467867 ↗ A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL Recruiting Georgetown University Phase 2 2018-04-26 This is an open-label, multicenter, Phase II study to investigate the efficacy and safety of venetoclax in combination with Rituximab/hyaluronidase human in participants with relapsed or refractory chronic lymphocytic leukemia (CLL).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for RITUXAN HYCELA

Condition Name

Condition Name for RITUXAN HYCELA
Intervention Trials
Mantle Cell Lymphoma 2
Recurrent Grade 2 Follicular Lymphoma 1
Refractory Small Lymphocytic Lymphoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for RITUXAN HYCELA
Intervention Trials
Lymphoma 6
Lymphoma, Mantle-Cell 4
Lymphoma, B-Cell 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for RITUXAN HYCELA

Trials by Country

Trials by Country for RITUXAN HYCELA
Location Trials
United States 59
Canada 3
Greece 1
Israel 1
Korea, Republic of 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for RITUXAN HYCELA
Location Trials
Washington 4
Missouri 4
New York 3
New Jersey 3
Iowa 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for RITUXAN HYCELA

Clinical Trial Phase

Clinical Trial Phase for RITUXAN HYCELA
Clinical Trial Phase Trials
Phase 3 2
Phase 2 5
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for RITUXAN HYCELA
Clinical Trial Phase Trials
Recruiting 5
Not yet recruiting 2
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for RITUXAN HYCELA

Sponsor Name

Sponsor Name for RITUXAN HYCELA
Sponsor Trials
National Cancer Institute (NCI) 3
Academic and Community Cancer Research United 2
Acerta Pharma BV 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for RITUXAN HYCELA
Sponsor Trials
Other 7
NIH 3
Industry 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.